Livzon Pharmaceutical’s First-Quarter Profit Slips as Policy Shift and Seasonality Hit RevenueTip Ranks·Apr 23 at 09:11 AM000513+0.39%01513-0.38%
Livzon Pharmaceutical Outlines Board and Committee StructureTip Ranks·Mar 24 at 08:41 AM520690-0.28%1595060.00%
LIVZON PHARMA adjusts the maximum cost of acquiring its Vietnamese peer to RMB 1.85 billionAASTOCKS·Dec 30, 2025 at 08:13 AM000513+0.39%01513-0.38%
LIVZON PHARMA's application for marketing authorization of Lecanemab injection has been acceptedAASTOCKS·Dec 28, 2025 at 03:56 AM000513+0.39%01513-0.38%
On November 3rd, LIVZON PHARMA spent CNY 5.9969 million to repurchase 164,000 A sharesZhitong·Nov 3, 2025 at 03:50 AM000513+0.39%01513-0.38%
LIVZON GROUP has repurchased 1.7% of its shares at a cost of 570 million yuanZhitong·Nov 3, 2025 at 02:40 AM000513+0.39%01513-0.38%
Directly hitting the afternoon of the first day of the 2025 National Conference: Pfizer, Qilu, and many other Chinese and foreign companies enter the venueZhitong·Oct 30, 2025 at 01:19 AM000513+0.39%01513-0.38%
LIVZON PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 1.754 billion yuan, an increase of 4.86% year-on-yearZhitong·Oct 23, 2025 at 04:08 AM000513+0.39%01513-0.38%
As of the end of September, LIVZON PHARMA has repurchased a total of 15.3768 million A sharesZhitong·Oct 9, 2025 at 03:43 AM000513+0.39%01513-0.38%
HSBC Research's Investment Ratings and Target Prices for Pharmaceutical and Biotechnology Stocks (Table)AASTOCKS·Oct 2, 2025 at 02:07 AM000513+0.39%01513-0.38%
LIVZON GROUP: The company's semaglutide injection for weight loss indications has completed patient enrollment in Phase III clinical trialsZhitong·Sep 28, 2025 at 08:02 PM000513+0.39%01513-0.38%
On September 26th, LIVZON PHARMA spent CNY 4.9979 million to repurchase 130,800 A sharesZhitong·Sep 26, 2025 at 04:17 AM000513+0.39%01513-0.38%
On September 25th, LIVZON PHARMA spent CNY 4.9976 million to repurchase 129,300 A sharesZhitong·Sep 25, 2025 at 03:41 AM000513+0.39%01513-0.38%
On September 24th, LIVZON PHARMA spent CNY 4.9977 million to repurchase 128,300 A sharesZhitong·Sep 24, 2025 at 05:01 AM000513+0.39%01513-0.38%
